Addition of ALK inhibitor shows promise in enhancing CAR-T cell therapy for neuroblastoma
Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients’ T cells so they can better find and destroy tumor… Read More »Addition of ALK inhibitor shows promise in enhancing CAR-T cell therapy for neuroblastoma